Arca
Skip to content
Tools
Tools

SPRINT Peripheral Nerve Stimulation System, Extensa, SPRINT Peripheral Nerve Stimulation System, Endura, SPRINT Clinical Programmer Kit

Stimulator, Nerve, Electrical, Percutaneous (Pens), For Pain Relief. 510(k) K181422, from Spr Therapeutics, Inc. (Cleveland, OH). Product code NHI, class 2.

As of Nov 20, 2026, K181422 is an FDA 510(k) held by Spr Therapeutics, Inc., substantially equivalent on Jul 31, 2018 after 61 days, with no recalls tied to it in FDA's recall database.

  • Review time: 61 days
  • Recalls: 0
  • Cited as a predicate by: 2 devices

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The SPRINT Peripheral Nerve Stimulation (PNS) System is indicated for up to 60 days in the back and/or extremities for: • Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; • Symptomatic relief of post-traumatic pain; • Symptomatic relief of post-operative pain. The SPRINT PNS System is not intended to treat pain in the craniofacial region.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

2 later 510(k) summaries name this device as a predicate

Other NHI clearances

The newest 510(k)s for the same product code; their median review was 120 days; see every NHI device

Record

Type
Traditional
Received
May 31, 2018
Review panel
Neurology
Regulation
21 CFR 882.5890

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.